Inherited prothrombotic defects in Budd-Chiari syndrome and portal vein thrombosis: a study from North India

Am J Clin Pathol. 2004 Jun;121(6):844-7. doi: 10.1309/F2U1-XBV4-RXYU-AYG0.

Abstract

We studied 57 patients with Budd-Chiari syndrome (BCS) and 48 with portal vein thrombosis (PVT) for underlying inherited prothrombotic defects such as protein C, protein S, and antithrombin III deficiencies. Genetic mutations for factor V Leiden, prothrombin gene 20210A, and methyltetrahydrofolate reductase (MTHFR) C677T were studied in 29 patients in each group. Inherited prothrombotic defects were detected in 16 (28%) of 57 patients with BCS and 7 (15%) of 48 patients with PVT. Factor V Leiden mutation was the most common prothrombotic defect in BCS (5/29 [17%]) followed by protein C deficiency (7/57 [12%]) and protein S deficiency (4/57 [7%]), whereas in PVT, protein C deficiency was the most common inherited prothrombotic defect (4/48 [8%]) followed by protein S deficiency (2/48 [4%]). The factor V Leiden mutation was detected in only 1 (3%) of 29 cases of PVT. The heterozygous MTHFR C677T mutation was detected in 7 (24%) of 29 patients with BCS and 6 (21%) of 29 patients with PVT. Antithrombin III deficiency, homozygous MTHFR C677T mutation, and prothrombin G20210A mutation were not detected in any patients.

Publication types

  • Comparative Study

MeSH terms

  • Adolescent
  • Adult
  • Antithrombin III / metabolism
  • Budd-Chiari Syndrome / epidemiology
  • Budd-Chiari Syndrome / genetics*
  • Budd-Chiari Syndrome / pathology*
  • Child
  • Child, Preschool
  • Factor V / genetics
  • Female
  • Humans
  • India
  • Male
  • Methylenetetrahydrofolate Reductase (NADPH2) / genetics
  • Middle Aged
  • Mutation
  • Portal Vein / pathology*
  • Protein C / metabolism
  • Protein S / metabolism
  • Prothrombin / genetics
  • Venous Thrombosis / genetics*
  • Venous Thrombosis / pathology*

Substances

  • Protein C
  • Protein S
  • factor V Leiden
  • Antithrombin III
  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Reductase (NADPH2)